KDIGO

Don't miss "Team-Based Management of DD-CKD Anemia with New Treatment Strategies" on Wednesday, August 21, from 12:00 - 12:30 PM ET. Register: https://lnkd.in/gmBdmySe This #CME and #CNE symposium on #dialysis-dependent (DD) chronic kidney disease (#CKD) #anemia is designed to encourage the exchange of ideas between leaders in the field and attendees. Led by Kirsten Johansen, MD (United States), the webinar addresses clinical data for hypoxia-inducible factor prolyl-hydroxylase inhibitors (HIF-PHIs) for the treatment of DD-CKD anemia, the role of HIF-PHIs in managing DD-CKD anemia, and the importance of a team-based approach to patient treatment and monitoring.

Join us for "Team-Based Management of DD-CKD Anemia With New Treatment Strategies" on Wednesday, August 21, from 12:00 - 12:30 PM ET. Register: https://lnkd.in/gmBdmySe This CME symposium on dialysis-dependent (DD) chronic kidney disease (CKD) anemia is designed to encourage the exchange of ideas between leaders in the field and attendees. Led by Kirsten Johansen, MD (United States), the webinar addresses clinical data for hypoxia-inducible factor prolyl-hydroxylase inhibitors (HIF PHIs) for the treatment of DD-CKD anemia, the role of HIF PHIs in managing DD-CKD anemia, and the importance of a team-based approach to patient treatment and monitoring. #anemia #CKD #dialysis

Check out the Summer 2024 issue of KDIGO Direct for the latest news and updates from KDIGO: https://lnkd.in/e8Bnwf_n In this issue: KDIGO Complement Controversies Conference Report Published in Kidney International; KDIGO at the EDTNA/ECRA Conference, the Congresso Brasileiro de Nefologia, and the Wonca Europe Conference; upcoming events; new resources on #anemia, #CKD, #CKDaP, #dialysis care, #lupus, and more.

Did you know that CKD-associated pruritus (#CKDaP) is often underdiagnosed in patients on hemodialysis, significantly impacting their sleep and quality of life? Check out the free #CME activity, "I Just Need to Sleep! Improving Itch in Patients With CKD-aP," to explore effective strategies for improving the sleep and overall well-being of patients. Dive deep into the latest research and management options for patients with CKD-aP: https://lnkd.in/eB9tUfgt

Reminder: There is still time to share your feedback on the Scope of Work for the KDIGO Controversies Conference on the Relationship Between Obesity and CKD. The Scope of Work and feedback form are available through Monday, August 5, and can be found on the conference website: https://lnkd.in/ed8AVrVu KDIGO thanks you for your time and insights.

Join us for the International Society of Nephrology-International Pediatric Nephrology Association (IPNA)-KDIGO webinar: Contemporary Management of SSNS and SRNS - Latest Guidance From IPNA & KDIGO on Monday, July 29 at 5 pm CEST/ 11 am EDT. Learn more and register: https://lnkd.in/e_ksN938 Moderated by Michelle Denburg and featuring speakers Marina Vivarelli and Agnes Trautmann, this webinar will compare and contrast IPNA and KDIGO guidance on managing steroid-sensitive nephrotic syndrome (SSNS) and steroid-resistant nephrotic syndrome (SRNS) through detailed case vignettes. Learn about key similarities and get a preview of anticipated updates to KDIGO to the KDIGO Nephrotic Syndrome Guideline. We hope to see you there.

KDIGO is pleased to share the publication of the final report from the KDIGO Controversies Conference on the Role of Complement in Kidney Disease. Read the news release: https://lnkd.in/eynbGVqE Download the report: https://lnkd.in/ezA95Hr4 Read the report in Kidney International: https://lnkd.in/eEhdYujn Co-chaired by Marina Vivarelli, MD (Italy) and Richard Smith, MD (United States) in Florence, Italy, in 2022, the conference gathered leading nephrologists, researchers, patients, and caregivers to discuss the latest evidence and future directions for managing complement-mediated kidney diseases, particularly aHUS, C3G, AAV, IgAN, SLE, FSGS, and diabetic nephropathy. Dr. Smith said, "It is clear that we need a concerted, multinational effort to make meaningful progress in our understanding and treatment of these mostly rare and heterogeneous kidney diseases. We need to identify biomarkers of complement activation and dysregulation, standardize their measurement, and promote their global implementation...This collaborative approach will enable us to offer early, accurate diagnosis and safe, effective, and affordable treatment tailored to individual patients." Dr. Vivarelli said, "The presence of patients and their caregivers was invaluable. Their stories and experiences brought a profound human element to our discussions by reminding us of the real-world implications of our research and the importance of patient-centered care. Their contributions emphasized the need for therapies that address the medical aspects of these diseases and improve the quality of life for those affected." #Complement #Glomerular #aHUS #C3G #FSGS #IgAN #AAV #ANCA #vasculitis #lupus #nephritis #diabetes #nephropathy #CKD

Join us for the webcast "KDIGO 2024 CKD Guideline Unpacked: Hear it Straight from the Experts" tomorrow, July 23, at 8:00 PM Indian Standard Time (IST). Register: https://lnkd.in/eFfCFRF6 Learn more: https://lnkd.in/eNCV3nZx The webcast, moderated by Dr. Vivekanand Jha and featuring presentations by Dr. Edgar Lerma and Dr. Giorgina Piccoli, will address the implications of the new KDIGO CKD Guideline and ways to delay the progression of #CKD.

How can we enhance care for patients with chronic kidney disease-associated pruritus, or CKD-aP? Check out the free CME webinar, Getting to the Root of CKD-Associated Pruritus - Questions From the Field: https://lnkd.in/eJXV3FWj In this program, Dr. Joel Topf and Dr. James Burton address frequent questions about managing CKD-aP. They tackle the impact of CKD-aP on patient quality of life and common challenges associated with treatment. Tune in to hear insights on proactive patient identification, personalized treatment plans, and novel therapies. #CME #MedEd #CKDaP #CKD #kidneydisease #nephrology #dermatology

KDIGO invites you to comment on the Scope of Work (SOW) for the KDIGO Controversies Conference on the Relationship Between Obesity and CKD: Pathophysiology, Prognosis, and Management. The SOW will be available for public review through Monday, August 5. The SOW and feedback form can be found on the conference website: https://lnkd.in/ed8AVrVu The conference, co-chaired by Dr. Susan Furth (Children's Hospital of Philadelphia and the Perelman School of Medicine at the University of Pennsylvania, United States) and Dr. Peter Rossing (Steno Diabetes Center Copenhagen and University of Copenhagen, Denmark), will be held in Prague, Czechia, from October 10 to 13. Obesity is a driver for diabetes and hypertension, the two leading causes of CKD in most countries, and obesity may also directly induce CKD. Treatment with an optimized diet and exercise is preferred but often difficult to sustain. While recent trials have shown positive outcomes in metabolic surgery or pharmacological interventions with substantial weight reductions maintained, questions remain about the relationship between obesity and CKD, how their coexistence relates to diagnosis, and optimal strategies for management, especially in people with CKD. This conference will bring together key thought leaders, patients, caregivers, and global experts from multiple disciplines to review the literature and current state of understanding in this area and address clinical issues as outlined in the SOW. The conference will involve topical plenary session presentations followed by focused discussion groups that will report back to the full group for consensus building. KDIGO thanks you for your time and insights. #obesity #ckd